EIR Nesher Pharmaceuticals (USA) Nov 2001

Gwyn Dickinson FDA, Michele Obert FDA$595.00 - Available Now

FDA investigators audited the Nesher Pharmaceuticals (USA) - Saint Louis, MO, United States facility and issued inspectional observation (via FDA 483) on 02 Nov 2001.

Product details

  • Category:
  • Inspection end: 02 Nov 2001
  • Location: Saint Louis, United States
  • FEI: 1937079
Add To Cart